Chernett Jorey's Form 4 filing
Starling Oncology, Inc.DFPH · filed Nov 10, 2026
- Accession no.
- 0000921895-26-003018
- Filed
- Nov 10, 2026, 6:33 PM ET
- Trade date
- Nov 6-10, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $176.3K. Open-market sales total $11.4M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chernett JoreyCIK 0002042077 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Common Stock | PPurchaseAcquired | +1,000,000 | $0.075 | +$750 | 10,000 | Direct | |
| Nov 6, 2026 | Common Stock | PPurchaseAcquired | +500,000 | $0.40 | +$2,000 | 5,000 | Direct | |
| Nov 9, 2026 | Common Stock | PPurchaseAcquired | +750,000 | $0.5357F4 | +$4,017.75 | 7,500 | Direct | |
| Nov 10, 2026 | Common Stock | PPurchaseAcquired | +700,000 | $0.67 | +$4,690 | 7,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.
Referenced by the price of 1 transaction in Table I.
- F2
The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
Referenced by the price of 2 transactions in Table I.
- F3
The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased.
Referenced by the price of 1 transaction in Table II.